← Back to Clinical Trials
Recruiting NCT07218731

NCT07218731 Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07218731
Status Recruiting
Phase
Sponsor Ohio State University
Condition Presbyopia Correction
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-12-08
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Multifocal contact lensesSpherical contact lenses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-12-08 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to assess participant experience when wearing multifocal contact lenses compared to spherical contact lenses with reading glasses.

Eligibility Criteria

Inclusion Criteria: 1. At least 40 years of age. 2. Ability to give informed consent. 3. Subjects must have corrected distance visual acuity in both eyes equivalent to 20/25 or better at the screening visit. 4. Require an add power of +0.75 D or greater when tested at 40cm. 5. Good general health defined by medication use that has not changed within the last 30 days and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the Investigator. Exclusion Criteria: 1. Current or active inflammation or infection as determined by the Investigator. 2. Current eye disease, infection or inflammation that affects the surface of the eye such as but not limited to moderate or greater blepharitis and ocular allergy. 3. History of refractive surgery. 4. Known history of allergy or sensitivity to contact lens solutions and/or sodium fluorescein. 5. Is pregnant or lactating or planning a pregnancy during enrollment of the study. 6. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. 7. Have been diagnosed with dry eye previously 8. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable.

Contact & Investigator

Central Contact

Study Coordinators

✉ OPT-EyeStudies@osu.edu

📞 614-292-8858

Frequently Asked Questions

Who can join the NCT07218731 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Presbyopia Correction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07218731 currently recruiting?

Yes, NCT07218731 is actively recruiting participants. Contact the research team at OPT-EyeStudies@osu.edu for enrollment information.

Where is the NCT07218731 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT07218731 clinical trial?

NCT07218731 is sponsored by Ohio State University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology